Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Citi lifts its TMUS price target to $225, citing robust cash flow and a big buyback. The call comes as investors weig...
Opendoor Technologies shares jumped about 6% as the company posted a strong Q4 and policy tailwinds boosted the stock...
Uber stock jumps after AI chatter linked to Nvidia sparks a rally as the company details a 2027 robotaxi rollout and ...
A couple in their 40s discovers the $400,000 life policies bought in their 20s may no longer fit their evolving famil...
Rocket Lab climbs on Neutron milestones as investors weigh SpaceX IPO chatter. The move underscores growing appetite ...
Investors are eyeing a wave of next generation submarines as major powers expand fleets, raising costs and creating n...
Peloton pivots to the commercial gym market with a new Commercial Series, sending shares higher as it targets gym cha...
Nvidia signals a wave of AI data-center demand, but investors are eyeing Broadcom and ASML as durable infrastructure ...
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Oil prices rose again as investors weighed a mix of Middle East signals and shifting Iran policy on the Strait of Hor...
Bitcoin holds above $74,000 as policymakers prepare to announce rate decisions this week, setting the tone for crypto...